Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease Metadata

Metadata describes a digital item, providing (if known) such information as creator, publisher, contents, size, relationship to other resources, and more. Metadata may also contain "preservation" components that help us to maintain the integrity of digital files over time.

Title

  • Main Title Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
  • Series Title Background paper

Creator

  • Author: United States. Congress. Office of Technology Assessment.
    Creator Type: Organization

Publisher

  • Name: United States. Congress. Office of Technology Assessment.
    Place of Publication: [Washington D.C.]

Date

  • Creation: 1992-10

Language

  • English

Description

  • Content Description: This background paper describes the development of alglucerase, illustrates the role that both the Federal Government and private sector can have in making new therapies available for orphan diseases, and lays out some of the tradeoffs that can exist between developing new medical technologies and controlling health care costs.
  • Physical Description: 41 p. : ill. ; 28 cm.

Subject

  • Library of Congress Subject Headings: Gaucher's disease -- Treatment -- United States.
  • Library of Congress Subject Headings: Orphan drugs -- United States.
  • Library of Congress Subject Headings: Pharmaceutical policy -- United States.

Primary Source

  • Item is not a Primary Source

Coverage

  • Place Name: United States

Collection

  • Name: Office of Technology Assessment
    Code: OTA

Institution

  • Name: UNT Libraries Government Documents Department
    Code: UNTGD

Resource Type

  • Report

Format

  • Text

Identifier

  • Accession or Local Control No: 9214
  • SuDoc Number: Y 3.T 22/2:2 AL 3
  • UNT Catalog No.: b1720993
  • Archival Resource Key: ark:/67531/metadc39697

Note